You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. A Preclinical Trial of Therapeutic Angiogenesis Plus Angioplasty and Stenting for Renal Vascular Disease

    SBC: LEFLORE TECHNOLOGIES LLC            Topic: 400

    Abstract Chronic kidney disease CKD is a progressive disorder affecting almost of the general population and this disease has shown a relentless growth over the past decades Patients with CKD have higher rates of hospitalization greater mortality shorter life expectancy and their healthcare costs are up to times more expensive than non CKD patients Thus treatments to slow halt ...

    STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
  2. Biocatalytic production of precursors to lutein and zeaxanthin to address age related macular degeneration

    SBC: EscaZyme Biochemicals, LLC            Topic: N

    Project Summary Atrophic dry age related macular degeneration AMD is the leading cause of severe loss of vision for those over age Dietary supplements containing lutein and zeaxanthin are recommended by the NEI for those at risk of late AMD There has been a corresponding growth in demand for these two xanthophylls Lutein and zeaxanthin are currently sourced from marigolds grown mostl ...

    STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
  3. Developing Testing and Validating a Wearable Alcohol Biosensor

    SBC: Clinitech, LLC            Topic: 450

    PROJECT SUMMARY This application for a Phase I SBIR award represents a collaboration between Clinitech LLC and McLean Hospital Harvard Medical School to develop a wearable biosensor for detecting alcohol in the interstitial fluid of humans who have consumed alcohol Excessive use of alcohol accounts for much of the public health burden related to alcohol use disorders including fetal ...

    SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
  4. Synthesis of HAN and HEHN in a Continuous Mix Process

    SBC: Digital Solid State Propulsion, Inc            Topic: AF171061

    Production of hydroxylamine nitrate (HAN) and hydroxyethyl hydrazine nitrate (HEHN) is of great concern for the manufacture of AF-315E. Current stockpiles of heritage ingredients held by AFRL are being depleted and those manufacturers are no longer in exi

    SBIR Phase I 2017 Department of DefenseAir Force
  5. High Voltage (HV) Fireset Systems and Subsystem Component Level Designs

    SBC: HYPERION TECHNOLOGY GROUP INC            Topic: AF171089

    Current and future explosive munition weapon systems development relies heavily on explosives detonation performance characterization and computational hydro-code simulation research conducted by DoD and DoE research communities. This work in turn relies

    SBIR Phase I 2017 Department of DefenseAir Force
  6. Prediction and Measurement of the Soot Build-Up in Film-Cooled Rocket Engines

    SBC: SIERRA ENGINEERING, INC.            Topic: AF15AT21

    This Phase II STTR effort is focused on generating the data necessary to identify the phenomenology that produces carbon deposition within kerosene film cooled rocket engines.This data is essential to guide the model development and validation process.Program outputs will be both data and a physics-based model for carbon deposition.

    STTR Phase II 2017 Department of DefenseAir Force
  7. SBIR Phase I: Novel Processing of Mesoporous Materials for Intermediate-Temperature Solid Oxide Fuel Cells

    SBC: ADVANCED MATERIALS & DEVICES            Topic: BC

    This Small Business Innovation Research Phase I project will demonstrate the feasibility of designing engineered mesoporous zirconia films for intermediate temperature (600ýýC) solid-oxide fuel cells (IT-SOFCs) with the aim of extending the basic and practical knowledge of synthesis as well as electronic behavior of mesoporous films, while at the same time producing materials that have a direct ...

    SBIR Phase I 2009 National Science Foundation
  8. STTR Phase II: Optimized Nano-Porous Surfaces for Boiling Heat Transfer

    SBC: ADVANCED MATERIALS & DEVICES            Topic: N/A

    This award is funded under the American Recovery and Reinvestment Act of 2009 (Public Law 111-5). This Small Business Technology Transfer Research (STTR) Phase II project seeks to develop and commercialize an optimized technique to produce durable nano-porous surfaces (NPS) for heat transfer applications using an inexpensive electrochemical process. This technology will be very beneficial for the ...

    STTR Phase II 2009 National Science Foundation
  9. STTR Phase I: Compressible Magnetorheological Fluids

    SBC: ADVANCED MATERIALS & DEVICES            Topic: MM

    This award is funded under the American Recovery and Reinvestment Act of 2009 (Public Law 111-5). This Small Business Technology Transfer (STTR) Phase I project seeks to develop stable and optimal compressible magneto-rheological fluids (CMRFs) and to perform device tests on such fluids to demonstrate their durability. The production of stable and durable CMRFs will be achieved by using an inexpe ...

    STTR Phase I 2009 National Science Foundation
  10. Thermally Targeted Delivery of Therapeutic Peptides

    SBC: Thermally Targeted Therapeutics, Incorporated            Topic: N/A

    DESCRIPTION (provided by applicant): Current treatment of solid tumors is limited by normal tissue tolerance, inherent tumor resistance to radiation or chemotherapy, and toxicity from systemic administration of antineoplastic agents. The result is a narrow therapeutic index for most current chemotherapeutic agents. Our long term goal is to overcome these limitations by developing a targeted therap ...

    SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government